Chongqing Taiji Industry(Group) Co.,Ltd (SHA:600129)

Market Cap	7.77B -33.1%
Revenue (ttm)	10.20B -7.3%
Net Income	111.65M
EPS	0.21
Shares Out	551.42M
PE Ratio	68.33
Forward PE	28.18
Dividend	n/a
Ex-Dividend Date	n/a

Volume	20,830,285
Open	13.66
Previous Close	13.60
Day's Range	13.66 - 14.16
52-Week Range	11.56 - 25.51
Beta	0.23
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 26, 2026

About SHA:600129

Chongqing Taiji Industry(Group) Co.,Ltd, together with its subsidiaries, engages in the production and sales of Chinese and western medicine products in China and internationally. It operates through Pharmaceutical Industry; Pharmaceutical Business; Chinese medicinal materials Resources; Big Health and International; and Service Industry and Others segments. The company offers respiratory system, digestive system and metabolic, nervous system, cardiovascular and cerebrovascular, big health, anti-infective, anti-tumor, immunomodulatory drugs; an...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1979
• Employees: 10,864
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600129

Financial Performance

In 2025, SHA:600129's revenue was 10.50 billion, a decrease of -15.23% compared to the previous year's 12.39 billion. Earnings were 120.57 million, an increase of 352.37%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jul 3, 2026

Data Sources Report a data error